Prism Ventures

CoAxia raises $21.5 million to complete trial of stroke device

CoAxia thinks its NeuroFlo technology could be part of basic care for 500,000 ischemic stroke patients, breaking into a market worth more than $1 billion. Instead of attacking the brain clot, its catheter diverts blood flow from the lower parts of the body and pushes it into the brain to increase blood flow.

By Chris Seper

News

Minnesota atrial fibrillation company Atritech raises $30 million

The new $30 million investment will help the atrial fibrillation device maker Atritech complete a U.S. Food and Drug Administration review and launch its product in Europe.

By Chris Seper

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.